Skip to main content

Injectable Collagen–Genipin Gel for the Treatment of Spinal Cord Injury: In Vitro Studies

Buy Article:

$43.00 plus tax (Refund Policy)


Spinal cord injury (SCI) often results in a cavitary lesion, contained within the dura, which involves only a portion of the cord. Injectable biopolymers are an attractive treatment option for SCI to re‐establish cell migratory pathways within the lesion while minimizing the collateral damage attendant to an open surgical procedure. In this study we evaluate a thermoresponsive soluble collagen gel incorporating genipin, an amine reactive covalent cross‐linker with low cytotoxicity and fluorogenic attributes. Unlike previous studies, genipin is being investigated as an in situ covalent cross‐linker that will continue to act on the gel after injection. Physical characterization studies show that the addition of genipin provides control over the mechanical and degradative behavior of the gel, to meet design specifications of an injectable material for neural tissues. Additionally, an improved in situ assay to predict the extent of cross‐linking reaction is investigated. Encapsulation of mesenchymal stem cells (MSCs) in collagen–genipin gels show the gels support cell viability and proliferation, and thus serve as a cell delivery vehicle. Neural stem cells are found to be more sensitive to genipin, with respect to toxicity, as compared to MSCs. From our studies, 0.25‐0.5 mM is an appropriate genipin concentration to use for an in situ forming scaffold capable of delivering cells and therapeutic agents.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Document Type: Research Article

Affiliations: 1: Health Sciences and Technology and Tissue Engineering, Harvard-Massachusetts Institute of Technology, VA Boston Healthcare System, 150 S. Huntington Ave D1-151, Boston, MA 02130, USA 2: Materials Science and Engineering and Tissue Engineering, Massachusetts Institute of Technology, VA Boston Healthcare System, 150 S. Huntington Ave D1-151, Boston, MA 02130, USA 3: Tissue Engineering and Orthopaedic Research Laboratory, VA Boston Healthcare System, Brigham and Women's Hospital, Harvard Medical School, 150 S. Huntington Ave D1-154, Boston, MA 02130, USA

Publication date: 2011-12-20

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more